World News: 14:47 GMT Thursday 3rd January 2019. [ImmusanT, Inc. via Globe Newswire via SPi World News]
CAMBRIDGE Mass Jan 03 2019 GLOBE NEWSWIRE -- a clinical-stageleveraging its Epitope-Specific Immuno-Therapy ESIT platform to deliver first-in-class peptide-based immunomodulatory therapies to patients with une dis...
Globe Newswire: 14:47 GMT Thursday 3rd January 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.